Podcast

Stephen Harrison, MD, on the REGENERATE Clinical Trial of Obeticholic Acid for NASH

10/28/2019

In this podcast, Stephen Harrison, MD, highlights the importance of new treatment options for patients with nonalcoholic steatohepatitis, findings from the REGENERATE clinical trial that were presented at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting and Postgraduate Course, and more.

Stephen Harrison, MD, is medical director of Pinnacle Clinical Research in San Antonio, Texas, and a visiting professor of hepatology at the University of Oxford in Oxford, England. 

 

Reference:

Harrison S. Positive results from REGENERATE: a phase 3 international, randomized, placebo-controlled study evaluating obeticholic acid treatment for NASH [abstract 11]. Presented at: ACG 2019 Annual Scientific Meeting and Postgraduate Course; October 25-30, 2019; San Antonio, TX.

 

Related Content

Pulmonology
Pulmonology
Albert Rizzo, MD, on the 2021 State of Tobacco Control Report
02/25/2021
In this podcast, Albert Rizzo, MD, from the American Lung Association, discusses the recently released State of Tobacco Control Report and the United States smoking epidemic.
02/25/2021
prevention
prevention
Albert Rizzo, MD, on Preventing Future Respiratory Pandemics: the American Lung Association’s New Initiative
03/19/2022
In this podcast, Albert A. Rizzo, MD, chief medical officer of the ALA, explains what developments to expect from the $25 million COVID-19 Action Initiative.
03/19/2022
Ovarian Cancer
Ovarian Cancer
Ovarian Cancer Screening
07/03/2022
Jenna Marcus, MD, from Rutgers New Jersey Medical School, discusses ovarian cancer risk stratification, screening and prophylactic strategies among populations with elevated ovarian cancer risk, and current...
07/03/2022
Infectious Diseases
Infectious Diseases
Matt Freiberg, MD, on Sudden Cardiac Death in HIV
03/10/2019
Dr Matt Freiberg, from Vanderbilt University Medical Center, discusses his research "Sudden Cardiac Death Among HIV-Infected and HIV-Uninfected Veterans," which he presented at CROI 2019. He also talks...
03/10/2019
Psoriatic Arthritis
Psoriatic Arthritis
Philip J. Mease, MD, on a New Interleukin Antagonist as Therapy for Psoriatic Arthritis
09/12/2019
Philip J. Mease, MD, from Swedish Medical Center, discusses his research on an anti-interleukin-23p19 monoclonal antibody that may be a potential therapeutic option for the treatment of psoriatic...
09/12/2019